| f46f858f-8031-4b4c-92f6-d38ba7ee2773 | F TRANSF LEUC MIEL CR(INCL ANTIB PROFIL) 2 LINHA | 29071160 | A | 1 | 2025-10-17T17:04:12.259485+00:00 | 2025-10-17T17:04:12.259485+00:00 |
| 1dcd4e61-d9a6-44d1-8fe2-a3f345cf10bb | F BLASTICA LEUC MIEL CR(SEM TRAT ANT 2LINHA) 1 LINHA | 29071178 | A | 1 | 2025-10-17T17:04:12.261117+00:00 | 2025-10-17T17:04:12.261117+00:00 |
| 6e8fe48b-68af-4503-879a-04cd20e72066 | F BLASTICA LEUC MIEL CR(COM TRAT ANT 2LINHA) 1 LINHA | 29071186 | A | 1 | 2025-10-17T17:04:12.262897+00:00 | 2025-10-17T17:04:12.262897+00:00 |
| 315e7e18-d6ca-4215-ab88-07122bf66133 | F BLASTICA LEUC MIEL CR(INCLUI PROFILATICOS) 2 LINHA | 29071194 | A | 1 | 2025-10-17T17:04:12.264397+00:00 | 2025-10-17T17:04:12.264397+00:00 |
| 0e9e74b2-c81f-4030-816c-68fd438a3e7a | CARCINOMA EPIDERMOIDE DOS SEIOS PARA-NASAIS, LARINGE E HIPOF | 29081017 | A | 1 | 2025-10-17T17:04:12.266295+00:00 | 2025-10-17T17:04:12.266295+00:00 |
| 2b674816-7f75-4e4a-aba6-60081bf23892 | CARCINOMA DE NASOFARINGE | 29081025 | A | 1 | 2025-10-17T17:04:12.267792+00:00 | 2025-10-17T17:04:12.267792+00:00 |
| 31a86a0c-60f7-43da-bef9-d61adf487c9c | ATENDIMENTO HIPERTENSAO ARTERIAL NORMAL - SEXO MASCULINO | 01022261 | A | 1 | 2025-09-16T17:35:03.282058+00:00 | 2025-09-16T17:35:03.282058+00:00 |
| e7ae393b-34bd-48ee-b135-7b6fd6fbe6a3 | AMNIOSCOPIA | 29001013 | H | 1 | 2025-10-17T17:04:12.156389+00:00 | 2025-10-17T17:04:12.156389+00:00 |
| 132bb698-7d44-43a2-a65e-053581bd561f | AMNIOCENTESE | 29002010 | H | 1 | 2025-10-17T17:04:12.158162+00:00 | 2025-10-17T17:04:12.158162+00:00 |
| 774d8571-9cb4-4caf-85c7-2790095717fe | CARCINOMA EPIDERMOIDE OU ADENOCARCINOMA DE ESOFAGO (ESTADIO | 29081050 | A | 1 | 2025-10-17T17:04:12.272831+00:00 | 2025-10-17T17:04:12.272831+00:00 |
| aaa39eec-2ee2-44df-b9dc-419ad14c162c | CARCINOMA EPIDERMOIDE OU ADENOCARCINOMA DO COLO UTERINO (EST | 29081084 | A | 1 | 2025-10-17T17:04:12.277848+00:00 | 2025-10-17T17:04:12.277848+00:00 |
| fbe2dfbb-88b3-49c0-baaa-8311f00765fa | CARCINOMA EPIDERMOIDE DE VULVA | 29081092 | A | 1 | 2025-10-17T17:04:12.279482+00:00 | 2025-10-17T17:04:12.279482+00:00 |
| 4daec2bf-f5ad-46d9-b1e7-8637242bb15c | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 1a L | 29091012 | A | 1 | 2025-10-17T17:04:12.281295+00:00 | 2025-10-17T17:04:12.281295+00:00 |
| 74ecf70c-6071-4911-8dbd-807310fcaa71 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 2a | 29091020 | A | 1 | 2025-10-17T17:04:12.283226+00:00 | 2025-10-17T17:04:12.283226+00:00 |
| 02ccc7c4-5590-4121-b955-1ab8e21d4535 | CARCINOMA DE MAMA (AMBOS OS SEXOS) - (ESTADIO III) - QUIM | 29091039 | A | 1 | 2025-10-17T17:04:12.285412+00:00 | 2025-10-17T17:04:12.285412+00:00 |
| 9b774a72-6bf4-49be-8e15-5507c9d42625 | CARCINOMA DE BEXIGA (ESTADIO III) | 29091055 | A | 1 | 2025-10-17T17:04:12.289221+00:00 | 2025-10-17T17:04:12.289221+00:00 |
| 3c50856d-72c7-4dfc-8440-043603337f3c | SARCOMA OSSEO/OSTEOSSARCOMA 1a LINHA | 29091063 | A | 1 | 2025-10-17T17:04:12.291068+00:00 | 2025-10-17T17:04:12.291068+00:00 |
| 3405c298-4baf-4cbd-b06b-01b0bb18d5fd | OSTEOSSARCOMA - 2a LINHA | 29091071 | A | 1 | 2025-10-17T17:04:12.292805+00:00 | 2025-10-17T17:04:12.292805+00:00 |
| 9967f4c8-7378-4bbf-a706-455e1cbc381a | CARCINOMA DE NASOFARINGE (ESTADIOS III e IV) SEM METASTASE | 29101018 | A | 1 | 2025-10-17T17:04:12.294727+00:00 | 2025-10-17T17:04:12.294727+00:00 |
| 0a8c2500-cb12-4454-a24e-17c59764a793 | CARCINOMA EPIDERMOIDE DE CABECA E PESCOCO | 29101026 | A | 1 | 2025-10-17T17:04:12.296861+00:00 | 2025-10-17T17:04:12.296861+00:00 |
| 6d81ecf4-1536-4904-b647-5bc72231cac5 | CARCINOMA PULMONAR DE CELULAS NAO PEQUENAS (ESTADIO III B) | 29101034 | A | 1 | 2025-10-17T17:04:12.299419+00:00 | 2025-10-17T17:04:12.299419+00:00 |
| e7367ddc-0436-442e-89f6-38a608fd4072 | CARCINOMA PULMONAR INDIFERENCIADO DE CELULAS PEQUENAS (DOENC | 29101050 | A | 1 | 2025-10-17T17:04:12.303818+00:00 | 2025-10-17T17:04:12.303818+00:00 |
| 003e8e59-0838-40e9-b7a4-8aa657685f68 | ADENOCARCINOMA DE COLON (ESTADIOS II e III ou DUKES B e C) | 29101069 | A | 1 | 2025-10-17T17:04:12.305849+00:00 | 2025-10-17T17:04:12.305849+00:00 |
| 47ca1280-e5de-4d62-9ebe-d1d3395a396a | ADENOCARCINOMA DE RETO (ESTADIOS II e III ou DUKES B e C) | 29101077 | A | 1 | 2025-10-17T17:04:12.307726+00:00 | 2025-10-17T17:04:12.307726+00:00 |
| ac5fa711-2176-4661-96cf-bd11080edc9c | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIOS IA e IB/G3. | 29101085 | A | 1 | 2025-10-17T17:04:12.309521+00:00 | 2025-10-17T17:04:12.309521+00:00 |
| 24a33c42-108c-4fad-a387-e0a8e4546c77 | NEOPLASIA DE CELULAS GERMINATIVAS DE OVARIO | 29111021 | A | 1 | 2025-10-17T17:04:12.311258+00:00 | 2025-10-17T17:04:12.311258+00:00 |
| a1034111-d875-4112-836f-ee405a0ffa63 | CARCINOMA DE MAMA (ESTADIO I CLINICO OU PATOLOGICO) RECEPTOR | 29111030 | A | 1 | 2025-10-17T17:04:12.316138+00:00 | 2025-10-17T17:04:12.316138+00:00 |
| ad9df477-7f4d-4859-a408-bb1ca4b43c96 | CARCINOMA DE MAMA (ESTADIO II CLINICO OU PATOLOGICO - SEM LI | 29111048 | A | 1 | 2025-10-17T17:04:12.318284+00:00 | 2025-10-17T17:04:12.318284+00:00 |
| 81cc928a-bcc5-4c56-81c5-4a474a3bbe82 | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - SEM LI | 29111056 | A | 1 | 2025-10-17T17:04:12.320187+00:00 | 2025-10-17T17:04:12.320187+00:00 |
| aa385204-469a-48dd-b367-610574254497 | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - SEM LI | 29111064 | A | 1 | 2025-10-17T17:04:12.322067+00:00 | 2025-10-17T17:04:12.322067+00:00 |
| 0bc03c66-8a55-49cc-99c2-666cd1cc8cc8 | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - COM 1 | 29111072 | A | 1 | 2025-10-17T17:04:12.324491+00:00 | 2025-10-17T17:04:12.324491+00:00 |
| 28d4d96c-c134-4d18-a9cb-769483245578 | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - COM 1 | 29111080 | A | 1 | 2025-10-17T17:04:12.326721+00:00 | 2025-10-17T17:04:12.326721+00:00 |
| a7a36ec2-993e-45cf-96cc-718d0237a6af | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - COM 1 | 29111099 | A | 1 | 2025-10-17T17:04:12.329287+00:00 | 2025-10-17T17:04:12.329287+00:00 |
| d1cf8439-f026-4801-8a32-e0a179857d46 | CARCINOMA DE MAMA (ESTADIO I CLINICO OU PATOLOGICO) - HORMON | 29111102 | A | 1 | 2025-10-17T17:04:12.331570+00:00 | 2025-10-17T17:04:12.331570+00:00 |
| ff46e5e5-5620-4065-995a-e11735c78a27 | CARCINOMA DE MAMA(AMBOS OS SEXOS) (ESTADIO II CLINICO OU PA | 29121019 | A | 1 | 2025-10-17T17:04:12.334045+00:00 | 2025-10-17T17:04:12.334045+00:00 |
| 9eddb4a8-8489-4dc8-b810-b2eaa28ac64e | CARCINOMA DE MAMA(AMBOS OS SEXOS) (ESTADIO II CLINICO OU PAT | 29121027 | A | 1 | 2025-10-17T17:04:12.336229+00:00 | 2025-10-17T17:04:12.336229+00:00 |
| 516da6cd-f776-4f00-949a-1c228fad929a | CARCINOMA DE MAMA {ESTADIO II CLINICO OU PATOLOGICO - COM 4 | 29121035 | A | 1 | 2025-10-17T17:04:12.338612+00:00 | 2025-10-17T17:04:12.338612+00:00 |
| d2e61b95-dfa6-4d67-a0c7-b21c7a69dd81 | CARCINOMA DE MAMA {(AMBOS OS SEXOS) (ESTADIO III CLINICO OU | 29121043 | A | 1 | 2025-10-17T17:04:12.340633+00:00 | 2025-10-17T17:04:12.340633+00:00 |
| 25f98973-4bc8-4c47-be03-27a05bee5d75 | CARCINOMA DE MAMA {(AMBOS OS SEXOS) ESTADIO III CLINICO OU P | 29121051 | A | 1 | 2025-10-17T17:04:12.342215+00:00 | 2025-10-17T17:04:12.342215+00:00 |
| ff137bff-7405-45dc-b9b1-afea4e41123c | CARCINOMA DE MAMA {(AMBOS OS SEXOS ESTADIO III CLINICO OU PA | 29121060 | A | 1 | 2025-10-17T17:04:12.344706+00:00 | 2025-10-17T17:04:12.344706+00:00 |
| d44bd017-65ad-4d4f-b47d-0677ad466797 | SARCOMA DE PARTES MOLES - (G2 OU G3 TUMOR > 5 CM DE EXTREMID | 29121094 | A | 1 | 2025-10-17T17:04:12.347047+00:00 | 2025-10-17T17:04:12.347047+00:00 |
| 2e26e587-3ad1-4e3d-b2d2-595e85b29021 | OSTEOSSARCOMA | 29131014 | A | 1 | 2025-10-17T17:04:12.349084+00:00 | 2025-10-17T17:04:12.349084+00:00 |
| e37f753b-e58c-4c02-bf51-a2ad1742fbdf | SARCOMA OSSEO | 29131022 | A | 1 | 2025-10-17T17:04:12.350944+00:00 | 2025-10-17T17:04:12.350944+00:00 |
| 1d2e63be-18f8-4b9d-a6fb-6c372f533b5f | DOENCA DE HODGKIN - (ESTADIO I E II) | 29141010 | A | 1 | 2025-10-17T17:04:12.352865+00:00 | 2025-10-17T17:04:12.352865+00:00 |
| 9d0b2bdf-4591-4cb6-8722-5a7257f38796 | DOENCA DE HODGKIN (ESTADIO III E IV) - 1a LINHA | 29141028 | A | 1 | 2025-10-17T17:04:12.354710+00:00 | 2025-10-17T17:04:12.354710+00:00 |
| 8023683e-7f85-4e9a-be43-6cfcc2a5d22a | DOENCA DE HODGKIN(QUALQUER ESTADIO) - 2aLINHA | 29141036 | A | 1 | 2025-10-17T17:04:12.356453+00:00 | 2025-10-17T17:04:12.356453+00:00 |
| 918b82e8-3183-4a75-8564-bd6da28dcbc4 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 29141044 | A | 1 | 2025-10-17T17:04:12.358219+00:00 | 2025-10-17T17:04:12.358219+00:00 |
| d67619e1-ca85-40c9-af00-5c7eb8844cd3 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 29141052 | A | 1 | 2025-10-17T17:04:12.360097+00:00 | 2025-10-17T17:04:12.360097+00:00 |
| 137adbf6-8582-491f-89fb-3b4c92737f41 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO O | 29141060 | A | 1 | 2025-10-17T17:04:12.361980+00:00 | 2025-10-17T17:04:12.361980+00:00 |
| 8c750d5c-dd70-4fb0-b22e-616e80b6de0d | DOENCA LINFOPROLIFERATIVA RARA | 29141079 | A | 1 | 2025-10-17T17:04:12.364424+00:00 | 2025-10-17T17:04:12.364424+00:00 |